Meet IAG Bio Partnering at Jefferies Healthcare Conference, 2021.
IAG will be attending the 12th Annual Jefferies London Healthcare Conference, taking place November 16th to 19th 2021.
IAG Bio Partnering is focused on bringing strategic collaborators and smart investments to a diversified portfolio of innovative clinical-stage life sciences companies with the potential to become a licensed pharmaceutical product thus addressing unmet patient need in oncology, rheumatology, musculoskeletal, rare diseases, neurodegenerative, and immunology markets.
“Our portfolio companies take full advantage of a wide range of innovative R&D solutions, operational breadth and expertise, as well as risk-sharing financing and partnership models”, added Dr. Olga Kubassova, CEO of IAG.
In collaboration with the best academics of our time, IAG is at the forefront in bringing mechanisms for early visibility of study performance through.
More on our recent partnerships can be found here: https://www.ia-grp.com/trial-solutions/bio-partnering/
About Image Analysis Group (IAG)
IAG, Image Analysis Group is a unique partner to life sciences companies. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes. IAG bio-partnering takes a broader view on asset development bringing R&D solutions, operational breadth, radiological expertise via risk-sharing financing and partnering models.
Learn more: www.ia-grp.com
Reach out: firstname.lastname@example.org
Follow the Company: Linkedin